4crt
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
- | + | {{STRUCTURE_4crt| PDB=4crt | SCENE= }} | |
+ | ===Crystal structure of human monoamine oxidase B in complex with the multi-target inhibitor ASS234=== | ||
+ | {{ABSTRACT_PUBMED_24642166}} | ||
- | + | ==Function== | |
+ | [[http://www.uniprot.org/uniprot/AOFB_HUMAN AOFB_HUMAN]] Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOB preferentially degrades benzylamine and phenylethylamine. | ||
- | + | ==About this Structure== | |
+ | [[4crt]] is a 2 chain structure. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=4CRT OCA]. | ||
- | + | ==Reference== | |
+ | <ref group="xtra">PMID:024642166</ref><references group="xtra"/><references/> | ||
+ | [[Category: Monoamine oxidase]] | ||
+ | [[Category: Allan, J.]] | ||
+ | [[Category: Binda, C.]] | ||
+ | [[Category: Esteban, G.]] | ||
+ | [[Category: Marco-Contelles, J.]] | ||
+ | [[Category: Mattevi, A.]] | ||
+ | [[Category: Ramsay, R R.]] | ||
+ | [[Category: Samadi, A.]] | ||
+ | [[Category: Unzeta, M.]] | ||
+ | [[Category: Alzheimer's disease]] | ||
+ | [[Category: Drug design]] | ||
+ | [[Category: Enzyme]] | ||
+ | [[Category: Flavin]] | ||
+ | [[Category: Oxidoreductase]] |
Revision as of 09:20, 2 April 2014
Contents |
Crystal structure of human monoamine oxidase B in complex with the multi-target inhibitor ASS234
Template:ABSTRACT PUBMED 24642166
Function
[AOFB_HUMAN] Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOB preferentially degrades benzylamine and phenylethylamine.
About this Structure
4crt is a 2 chain structure. Full crystallographic information is available from OCA.
Reference
- Esteban G, Allan J, Samadi A, Mattevi A, Unzeta M, Marco-Contelles J, Binda C, Ramsay RR. Kinetic and structural analysis of the irreversible inhibition of human monoamine oxidases by ASS234, a multi-target compound designed for use in Alzheimer's disease. Biochim Biophys Acta. 2014 Mar 16. pii: S1570-9639(14)00056-9. doi:, 10.1016/j.bbapap.2014.03.006. PMID:24642166 doi:http://dx.doi.org/10.1016/j.bbapap.2014.03.006